Related Experiment Video
Updated: May 17, 2026
07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Personalized medicine in cardiovascular diseases
Moo-Sik Lee1, Andreas J Flammer, Lilach O Lerman
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. ; Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon, Korea.
Korean Circulation Journal
|October 24, 2012
Summary
Personalized medicine tailors treatments to individuals using genomics for better efficiency and safety. Despite its potential in cardiovascular diseases (CVDs), clinical adoption remains low, highlighting implementation challenges.
Area of Science:
- Genomics and Precision Medicine
- Cardiovascular Diseases
- Healthcare Policy
Background:
- Personalized medicine offers tailored healthcare decisions and practices.
- Genomics integration enhances preventive and therapeutic strategies.
- Cardiovascular field shows increased research but limited clinical application.
Purpose of the Study:
- To review concepts, strengths, limitations, and challenges of personalized medicine.
- To focus on the application and impact of personalized medicine in cardiovascular diseases (CVDs).
- To explore the role of individualized medicine in healthcare reform.
Main Methods:
- Literature review of personalized medicine concepts.
- Analysis of scientific publications in the cardiovascular field.
- Examination of challenges and potential solutions for clinical implementation.
Main Results:
- Personalized medicine promises improved therapy efficiency, safety, and cost-effectiveness.
- Significant growth in personalized medicine research for CVDs observed.
- Low adoption rates by cardiologists in the USA indicate implementation barriers.
Conclusions:
- Overcoming scientific and policy challenges is crucial for personalized medicine.
- Comprehensive understanding, clinical application, and evidence-based practices are key.
- Personalized medicine is pivotal for healthcare reform, especially in CVDs, and will reshape future healthcare systems.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...